{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:06:23Z","timestamp":1791230783968,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.lfs.2020.118986","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T11:50:11Z","timestamp":1609242611000},"page":"118986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Transcriptome analysis reveals the efficacy of ginsenoside-Rg1 in the treatment of nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"267","author":[{"given":"Danshan","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Hassam","family":"Fakhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongshu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shude","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lfs.2020.118986_bb0005","doi-asserted-by":"crossref","first-page":"184","DOI":"10.23736\/S0391-1977.16.02567-0","article-title":"Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease","volume":"42","author":"Koukias","year":"2017","journal-title":"Minerva Endocrinol."},{"issue":"16","key":"10.1016\/j.lfs.2020.118986_bb0010","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.lfs.2020.118986_bb0015","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: the major impact of China","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2020.118986_bb0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/nyas.12016","article-title":"Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals","volume":"1281","author":"Masuoka","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2020.118986_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1 Suppl","key":"10.1016\/j.lfs.2020.118986_bb0030","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.lfs.2020.118986_bb0035","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2337\/dc07-0349","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2020.118986_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.lfs.2020.118986_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hep.28524","article-title":"The globalization of nonalcoholic fatty liver disease: prevalence and impact on world health","volume":"64","author":"Rinella","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.lfs.2020.118986_bb0050","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.lfs.2020.118986_bb0055","first-page":"349","article-title":"Ginsenoside Rg1 protects cardiomyocytes from hypoxia-induced injury through the PI3K\/AKT\/mTOR pathway","volume":"73","author":"Qin","year":"2018","journal-title":"Pharmazie"},{"key":"10.1016\/j.lfs.2020.118986_bb0060","series-title":"Ginsenoside Rg1 Ameliorates Behavioral Abnormalities and Modulates the Hippocampal Proteomic Change in Triple Transgenic Mice of Alzheimer\u2019s Disease","first-page":"6473506","volume":"2017","author":"Nie","year":"2017"},{"key":"10.1016\/j.lfs.2020.118986_bb0065","article-title":"Ginsenoside Rg1 and the control of inflammation implications for the therapy of type 2 diabetes: a review of scientific findings and call for further research","volume":"104630","author":"Alolga","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.lfs.2020.118986_bb0070","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1631\/jzus.B1400204","article-title":"Ginsenoside Rg1 ameliorates oxidative stress and myocardial apoptosis in streptozotocin-induced diabetic rats","volume":"16","author":"Yu","year":"2015","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.lfs.2020.118986_bb0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.redox.2018.01.009","article-title":"Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: current and innovative therapeutic approaches","volume":"15","author":"Borrelli","year":"2018","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.lfs.2020.118986_bb0080","first-page":"357","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015"},{"issue":"12","key":"10.1016\/j.lfs.2020.118986_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"2","key":"10.1016\/j.lfs.2020.118986_bb0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","article-title":"Liver diseases in the Asia-Pacific region: a lancet gastroenterology & hepatology commission","volume":"5","author":"Sarin","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.lfs.2020.118986_bb0095","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.33573","article-title":"Nonalcoholic fatty liver disease","volume":"122","author":"Clark","year":"2002","journal-title":"Gastroenterology"},{"issue":"2 Suppl 1","key":"10.1016\/j.lfs.2020.118986_bb0100","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lfs.2020.118986_bb0105","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"issue":"40","key":"10.1016\/j.lfs.2020.118986_bb0110","doi-asserted-by":"crossref","first-page":"11289","DOI":"10.1073\/pnas.1613228113","article-title":"ACOX2 deficiency: a disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment","volume":"113","author":"Vilarinho","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.lfs.2020.118986_bb0115","doi-asserted-by":"crossref","first-page":"E710","DOI":"10.1152\/ajpendo.00052.2019","article-title":"Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2alpha\/PPARalpha pathway","volume":"317","author":"Chen","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.lfs.2020.118986_bb0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.canlet.2005.03.050","article-title":"Fatty acid metabolism pathway play an important role in carcinogenesis of human colorectal cancers by microarray-bioinformatics analysis","volume":"233","author":"Yeh","year":"2006","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.lfs.2020.118986_bb0125","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/hep.30950","article-title":"Hepatic IRF2BP2 mitigates nonalcoholic fatty liver disease by directly repressing the transcription of ATF3","volume":"71","author":"Fang","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.lfs.2020.118986_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21050559","article-title":"The traditional medicine and modern medicine from natural products","volume":"21","author":"Yuan","year":"2016","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"11","key":"10.1016\/j.lfs.2020.118986_bb0135","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1248\/bpb.b18-00132","article-title":"Ginsenoside Rg1 protects against non-alcoholic fatty liver disease by ameliorating lipid peroxidation, endoplasmic reticulum stress, and inflammasome activation","volume":"41","author":"Xu","year":"2018","journal-title":"Biol. Pharm. Bull."},{"issue":"12","key":"10.1016\/j.lfs.2020.118986_bb0140","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2174\/1389450116666150531155711","article-title":"Natural products on nonalcoholic fatty liver disease","volume":"16","author":"Xu","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.lfs.2020.118986_bb0145","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jep.2017.04.012","article-title":"Hepataprotective effects of ginsenoside Rg1 - a review","volume":"206","author":"Gao","year":"2017","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118986_bb0150","first-page":"6269","article-title":"Ginsenoside Rg1 ameliorates testicular senescence changes in Dgalinduced aging mice via antiinflammatory and antioxidative mechanisms","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.lfs.2020.118986_bb0155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.intimp.2018.03.017","article-title":"Protective effects of ginsenoside Rg1 on splenocytes and thymocytes in an aging rat model induced by d-galactose","volume":"58","author":"Sun","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.lfs.2020.118986_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/cells7120270","article-title":"Protective effects and target network analysis of ginsenoside Rg1 in cerebral ischemia and reperfusion injury: a comprehensive overview of experimental studies","volume":"7","author":"Xie","year":"2018","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.lfs.2020.118986_bb0165","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate immunity and inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig. Dis. Sci."},{"issue":"10","key":"10.1016\/j.lfs.2020.118986_bb0170","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1089\/ars.2016.6776","article-title":"Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis","volume":"26","author":"Spahis","year":"2017","journal-title":"Antioxid. Redox Signal."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052031746X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052031746X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T02:54:18Z","timestamp":1710384858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052031746X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":34,"alternative-id":["S002432052031746X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118986","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptome analysis reveals the efficacy of ginsenoside-Rg1 in the treatment of nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118986"}}